Alkermes Q2 2024 Earnings Preview
Viiv's Dovato as Effective as Gilead' Biktarvy for HIV but With Less Weight Gain
Notable Earnings Before Wednesday's Open
Here's How Much $1000 Invested In United Therapeutics 5 Years Ago Would Be Worth Today
AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst
Breaking Down Gilead Sciences: 10 Analysts Share Their Views
Gilead Sciences Analyst Ratings
Here Are Big Pharma's Leading Blockbuster Makers
Check Out What Whales Are Doing With GILD
Executive Reshuffles: Otis Worldwide, HSBC and Rockwell Automation in Focus
HC Wainwright & Co. Maintains Buy on Argenx, Raises Price Target to $504
Most Shorted S&P 500 Stocks in June
J&J Beats in Q2 as Pharma Segment Outperforms
Incyte, Moderna Among Most Shorted S&P 500 Healthcare Stocks in June
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $28,000 Today
Gilead Highlights Progress In Research Across HIV Prevention, Treatment And Cure Programs At AIDS 2024
What 13 Analyst Ratings Have To Say About Halozyme Therapeutics
Halozyme Therapeutics Analyst Ratings
Zai Lab And Argenx Get Approval For Efgartigimod Alfa SC Injection For Generalized Myasthenia Gravis In China
Genmab Upgraded at RBC on Valuation